国际肿瘤学杂志 ›› 2018, Vol. 45 ›› Issue (8): 494-498.doi: 10.3760/cma.j.issn.1673422X.2018.08.010

• 综述 • 上一篇    下一篇

脑膜瘤恶性进展的分子机制

刘厚杰,万经海   

  1. 100021 北京,国家癌症中心 国家肿瘤临床医学研究中心 中国医学科学院北京协和医学院肿瘤医院神经外科
  • 出版日期:2018-08-08 发布日期:2018-11-01
  • 通讯作者: 万经海,Email: wanjinghai@sina.com E-mail:wanjinghai@sina.com

Molecular mechanism in malignant progression of meningioma

Liu Houjie, Wan Jinghai   

  1. National Cancer Center; National Clinical Research Center for Cancer; Department of Neurosurgery, Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China
  • Online:2018-08-08 Published:2018-11-01
  • Contact: Wan Jinghai E-mail:wanjinghai@sina.com

摘要: 非典型及恶性脑膜瘤具有高侵袭性和易局部复发的特点,手术及放化疗等传统治疗手段效果有限。近年来,随着对脑膜瘤发病机制的深入研究和分子生物学技术的发展,发现一些新的生物学标志物在脑膜瘤的发生和恶性进展过程中发挥着重要作用。遗传学和表观遗传学因素是脑膜瘤恶性进展的重要因素,其中遗传学因素包括细胞增殖异常、细胞侵袭性增强、新生血管形成、细胞凋亡抑制、端粒酶活性改变等多个表型的改变。生物学标志物的发现可为更合理地针对高级别脑膜瘤进行早期诊断、分子靶向治疗及更精确地评估预后提供参考。

关键词: 脑膜瘤, 遗传学, 基因表达调控, 表型, 生物学标记

Abstract: Atypical and malignant meningiomas are characterized by high invasiveness and local recurrence. Traditional treatments such as surgery, radiotherapy and chemotherapy have limited effects. Recently, with the further study of the pathogenesis of meningioma and the development of molecular biology techniques, some new biomarkers have been found to play important roles in development and malignant progression of meningioma. Several genetic and epigenetic factors have been identified as contributing to the malignant progression of meningioma. Genetic factors include multiple phenotypic changes such as abnormal cell proliferation, increased cell invasiveness, angiogenesis, apoptosis inhibition, and changes in telomerase activity. And the discovery of biomarkers provides references for early diagnosis, molecular targeted therapy and prognosis assessment of highgrade meningiomas.

Key words: Meningioma, Genetics, Gene expression regulation, Phenotype, Biological markers